Nirvana Labs, LLC – Trademark Portfolio
Entity Type: 16
Nirvana Labs, LLC holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 9 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 7 Nice Classification classes. Currently, 6 trademarks are registered. Notable registered marks include ABLY, FILIUM, and WHATEVERPROOF. The owner is based in Seattle, WA.
14 W. Roy St.
Seattle, WA 98119
Showing of trademarks Trademarks
Trademark Classifications
Nirvana Labs, LLC's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Common metals and their alloys; metal building materials; transportable buildings of metal
Frequently Asked Questions
How many trademarks does Nirvana Labs, LLC have?
Nirvana Labs, LLC has 13 U.S. trademarks filed with the USPTO. Of these, 6 registered, 4 abandoned, 2 cancelled.
What trademark classes does Nirvana Labs, LLC file in?
Nirvana Labs, LLC files trademarks across 7 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 10 (Medical Apparatus), Class 24 (Fabrics), Class 5 (Pharmaceuticals), Class 18 (Leather Goods). Class 25 covers clothing, footwear, headgear.
What are Nirvana Labs, LLC's most well-known trademarks?
Nirvana Labs, LLC's registered trademark portfolio includes well-known marks such as ABLY, FILIUM, and WHATEVERPROOF. These are among 6 currently registered trademarks in the portfolio.
What is Nirvana Labs, LLC's trademark registration success rate?
Nirvana Labs, LLC has a 50% trademark registration rate, with 6 out of 12 resolved applications resulting in successful registration. Currently, 0 applications are pending review.